rethinkPeptides Search
Menu
Research citation

Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study.

Diabetes, obesity & metabolism, 26(11), 5222-5232

Citation

Huang, Yu-Nan; Liao, Wen-Ling; Huang, Jing-Yang; Lin, Yu-Jung; Yang, Shun-Fa; Huang, Chieh-Chen; Wang, Chung-Hsing; Su, Pen-Hua. (2024). Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study.. Diabetes, obesity & metabolism, 26(11), 5222-5232. https://doi.org/10.1111/dom.15869